Loyalty program for HIV prevention in drug shops for young women
AmbassADDOrs for Health: Supporting Young Women's Health Through Girl-friendly Drug Vendors
This study is testing a loyalty program in drug shops in Tanzania to see if it helps young women access HIV prevention services and contraception more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 140 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 2 sites (Mwanza and 1 other locations) |
| Trial ID | NCT05357144 on ClinicalTrials.gov |
What this trial studies
This study evaluates the Malkia Klabu intervention, a loyalty program designed to create adolescent-friendly drug shops in Tanzania where young women can access HIV prevention services and contraception. It involves a cluster-randomized controlled trial across 40 health facility catchment areas, with approximately 60-70 intervention drug shops. The program incentivizes young women through a loyalty card system that rewards purchases with prizes and provides free HIV self-test kits. Additionally, the study will explore supply-side factors affecting the program's effectiveness through a mixed-methods implementation science approach.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescent girls and young women living in the Mwanza and Shinyanga regions of Tanzania who seek HIV prevention and reproductive health services.
Not a fit: Patients who do not reside in the targeted regions or those who are not adolescent girls or young women may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve access to HIV prevention and contraception for adolescent girls and young women in Tanzania.
How similar studies have performed: Other studies have shown success with similar community-based interventions aimed at improving access to health services for young women, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
The primary unit of analysis are the wards, and within them, the drug shops who will be enrolled based on the following inclusion criteria: Inclusion Criteria: * Wards with no greater than 3 public health facilities; * Wards with no less than 4 drug shops; * Wards with health facilities that were greater than 20 KM from a primary or secondary road; and * Drug shop owners and staff in Shinyanga and Mwanza Regions of Tanzania who are aged 18 or older;
Where this trial is running
Mwanza and 1 other locations
- Mwanza Province — Mwanza, Tanzania (Recruiting)
- Shinyanga Province — Shinyanga, Tanzania (Recruiting)
Study contacts
- Principal investigator: Jenny X Liu, PhD — University of California, San Francisco
- Study coordinator: Jenny X Liu, PhD
- Email: jenny.liu2@ucsf.edu
- Phone: 415-502-5200
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.